Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 182

Results For "ENT"

10007 News Found

Agilent to improve analysis speeds of genomics bioinformatics
Digitisation | June 08, 2022

Agilent to improve analysis speeds of genomics bioinformatics

Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data


Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform
News | June 07, 2022

Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform

Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues


FDA publishes ANP’s polymeric drug excipient DMF
Drug Approval | June 06, 2022

FDA publishes ANP’s polymeric drug excipient DMF

The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.


Merck’s pembrolizumab demonstrates improvement in distant metastasis
News | June 06, 2022

Merck’s pembrolizumab demonstrates improvement in distant metastasis

Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).


Fortis Healthcare opens Healthcare Information Centre at Tirupati
Healthcare | June 04, 2022

Fortis Healthcare opens Healthcare Information Centre at Tirupati

The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.


RH Capital announces investments to improve women’s health
News | June 04, 2022

RH Capital announces investments to improve women’s health

RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.


Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing
People | June 03, 2022

Gilead Sciences appoints Stacey Ma as EVP, Pharmaceutical Development and Manufacturing

Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead


Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS
News | June 03, 2022

Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS

Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022


BGS Gleneagles launches its refurbished advanced emergency & trauma center
Healthcare | June 02, 2022

BGS Gleneagles launches its refurbished advanced emergency & trauma center

120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care


Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity
News | June 01, 2022

Jubilant HollisterStier enters into agreement of $149.6 mn with US Govt to expand critical vaccine manufacturing capacity

This agreement is in addition to the $92 million filling line expansion announced in November 2021